• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC.
Hereditas. 2026 Jan 19;163(1):23. doi: 10.1186/s41065-025-00626-x.
2
NSUN2-mediated m5C modification of PGK1 mRNA promotes cell growth, invasion, stemness and glycolysis in gastric cancer.NSUN2介导的PGK1 mRNA的m5C修饰促进胃癌细胞的生长、侵袭、干性和糖酵解。
Cell Cycle. 2025 Aug 12:1-13. doi: 10.1080/15384101.2025.2544829.
3
NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.SUMO-2/3 修饰的 NSUN2 促进胃癌进展并调节 mRNA m5C 甲基化。
Cell Death Dis. 2021 Sep 9;12(9):842. doi: 10.1038/s41419-021-04127-3.
4
NSUN2 mediated-aberrant 5-methylcytosine methylation regulates autophagy-related ferroptosis in oral squamous cell carcinoma progression.
Cell Death Dis. 2025 Dec 23;16(1):903. doi: 10.1038/s41419-025-08174-y.
5
5-Methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer.5-甲基胞嘧啶转移酶NSUN2驱动非小细胞肺癌中NRF2介导的铁死亡抗性。
J Biol Chem. 2024 Apr;300(4):106793. doi: 10.1016/j.jbc.2024.106793. Epub 2024 Feb 24.
6
NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1.
Mol Carcinog. 2026 Jan;65(1):138-145. doi: 10.1002/mc.70060. Epub 2025 Nov 2.
7
NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma.NSUN2 通过调控 m5C RNA 修饰依赖的 Wnt 信号通路促进肝癌进展。
Oncogene. 2024 Nov;43(47):3469-3482. doi: 10.1038/s41388-024-03184-0. Epub 2024 Oct 7.
8
NSUN2-mediated RNA mC modification drives multiple myeloma progression by enhancing the stability of HIP1 mRNA.NSUN2介导的RNA mC修饰通过增强HIP1 mRNA的稳定性驱动多发性骨髓瘤进展。
Sci Rep. 2025 Jul 31;15(1):27888. doi: 10.1038/s41598-025-13695-9.
9
NSUN2 Knockdown Promotes the Ferroptosis of Colorectal Cancer Cells Via m5C Modification of SLC7A11 mRNA.NSUN2基因敲低通过对SLC7A11 mRNA进行m5C修饰促进结肠癌细胞的铁死亡
Biochem Genet. 2025 Feb 7. doi: 10.1007/s10528-025-11035-0.
10
Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1.长链非编码 RNA DIAPH2-AS1 通过稳定 NSUN2 增强 NTN1 的 m5C 修饰促进胃癌的神经侵袭。
Cell Death Dis. 2023 Apr 10;14(4):260. doi: 10.1038/s41419-023-05781-5.

本文引用的文献

1
Single-cell and spatial transcriptome profiling identifies the immunosuppressive spatial niche in -mutant colorectal cancer.单细胞和空间转录组分析确定了突变型结直肠癌中的免疫抑制性空间生态位。
J Immunother Cancer. 2025 Dec 31;13(12):e013763. doi: 10.1136/jitc-2025-013763.
2
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma.线粒体通路特征(MitoPS)可预测免疫治疗反应,并揭示NDUFB10是肺腺癌中的关键免疫调节因子。
J Immunother Cancer. 2025 Jul 31;13(7):e012069. doi: 10.1136/jitc-2025-012069.
3
NSUN2-mediated RNA methylation: Molecular mechanisms and clinical relevance in cancer.NSUN2 介导的 RNA 甲基化:癌症中的分子机制和临床相关性。
Cell Signal. 2024 Nov;123:111375. doi: 10.1016/j.cellsig.2024.111375. Epub 2024 Aug 30.
4
Extracellular vesicle-packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models.来自癌症相关成纤维细胞的细胞外囊泡包裹的 PIAT 通过介导胰腺癌小鼠模型中的 m5C 修饰来驱动神经重塑。
Sci Transl Med. 2024 Jul 17;16(756):eadi0178. doi: 10.1126/scitranslmed.adi0178.
5
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development.胃癌免疫抑制微环境异质性:对治疗开发的启示。
Trends Cancer. 2024 Jul;10(7):627-642. doi: 10.1016/j.trecan.2024.03.008. Epub 2024 Apr 9.
6
NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization.NSUN2通过增强SKIL mRNA稳定性促进结直肠癌进展。
Clin Transl Med. 2024 Mar;14(3):e1621. doi: 10.1002/ctm2.1621.
7
EPYC functions as a novel prognostic biomarker for pancreatic cancer.EPYC 可作为胰腺癌的一种新型预后生物标志物。
Sci Rep. 2024 Jan 6;14(1):719. doi: 10.1038/s41598-024-51478-w.
8
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via mC modification of SLC7A11 mRNA.表观遗传上调的 NSUN2 通过 SLC7A11 mRNA 的 mC 修饰赋予子宫内膜癌对铁死亡的抗性。
Redox Biol. 2024 Feb;69:102975. doi: 10.1016/j.redox.2023.102975. Epub 2023 Nov 29.
9
m5C-methylated lncRNA NR_033928 promotes gastric cancer proliferation by stabilizing GLS mRNA to promote glutamine metabolism reprogramming.m5C 甲基化长非编码 RNA NR_033928 通过稳定 GLS mRNA 促进谷氨酰胺代谢重编程来促进胃癌增殖。
Cell Death Dis. 2023 Aug 15;14(8):520. doi: 10.1038/s41419-023-06049-8.
10
Gastric cancer treatment: recent progress and future perspectives.胃癌治疗:最新进展与未来展望。
J Hematol Oncol. 2023 May 27;16(1):57. doi: 10.1186/s13045-023-01451-3.

NSUN2 restrains gastric cancer cell apoptosis and ferroptosis by promoting the m5C modification of EPYC.

作者信息

Wu Lei, Chen Boxuan, Cheng Si, Fang Xiaofeng, Zhou Fen

机构信息

Department of Gastrointestinal surgery, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, No. 228, Jingui Road, Xian 'an District, Xianning City, Hubei Province, 437100, China.

Department of Gastroenterology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning City, Hubei Province, 437100, China.

出版信息

Hereditas. 2026 Jan 19;163(1):23. doi: 10.1186/s41065-025-00626-x.

DOI:10.1186/s41065-025-00626-x
PMID:41549314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12895582/
Abstract

BACKGROUND

Epiphycan (EPYC) has been confirmed to play an oncogenic role in many cancers. However, its role and mechanism in gastric cancer (GC) progression has not been explored.

METHODS

The levels of EPYC and NOP2/Sun domain 2 (NSUN2) were detected by qRT-PCR and western blot. Cell proliferation, apoptosis, migration and invasion were determined by cell counting kit 8 assay, colony formation assay, flow cytometry, wound healing assay and transwell assay. Fe and iron levels were examined to assess cell ferroptosis. Actinomycin D assay was used to detect the effect of NSUN2 knockdown on EPYC mRNA stability, and methylated RNA immunoprecipitation (MeRIP) assay was performed to determine the effect of NSUN2 silencing on 5-methylcytosine (m5C) level of EPYC. Xenograft tumors were constructed to explore the regulation of NSUN2 knockdown on GC tumorigenesis in vivo.

RESULTS

EPYC was abnormally higher expressed in GC tissues and cells. Knockdown of EPYC restrained GC cell proliferation, migration and invasion, while enhanced apoptosis and ferroptosis. NSUN2 had elevated expression in GC, which could increase the mRNA stability and expression of EPYC through m5C modification. NSUN2 silencing inhibited GC cell proliferation, metastasis, promoted apoptosis and ferroptosis, while these effects were reversed by EPYC overexpression. In vivo experiments revealed that NSUN2 downregulation reduced GC tumorigenesis by decreasing EPYC level in vivo.

CONCLUSION

NSUN2-mediated m5C modification of EPYC contributed to GC cell growth and metastasis, which provided a novel regulatory axis for understanding the pathogenesis of GC.

摘要